The American Cancer Society has awarded a $792,000 multi-year research grant to John Ebos, PhD, of the Department of Pharmacology and Therapeutics at Roswell Park.
Patients with metastatic kidney cancer often stop treatment when the tumor becomes resistant to the drugs they are receiving. In many cases, the tumor can immediately begin to grow again. Dr. Ebos is studying a vaccine to inhibit the tumor growth that often happens when treatment has stopped, providing much-needed time to identify new treatment options for the patient.